Clinical Trial Update: Study of Individuals and Families With Aberrations in DDX41 or Similar Cancer Predisposition Variants

View source ↗

Summary

Clinical trial sponsored by the National Cancer Institute studying individuals and families with DDX41 or similar cancer predisposition variants, focusing on ge…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia
• Myelodysplastic Syndromes

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Germline Mutation, Myelodysplastic Syndromes | Status: RECRUITING